Effectiveness and Safety of Anti-CD19 Chimeric Antigen Receptor-T Cell Immunotherapy in Patients With Relapsed/Refractory Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis

Aim: To investigate the effectiveness and safety of using chimeric antigen receptor (CAR) T cell therapies targeting CD19 in patients with diffuse large B-cell lymphoma (DLBCL). Methods: PubMed, Embase, and the Cochrane Library were searched for reports published from database inception up to July 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Ying, Zhitao, Song, Yuqin, Zhu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081610/
https://www.ncbi.nlm.nih.gov/pubmed/35548364
http://dx.doi.org/10.3389/fphar.2022.834113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081610/
https://www.ncbi.nlm.nih.gov/pubmed/35548364
http://dx.doi.org/10.3389/fphar.2022.834113

Ejemplares similares